Up till now the role of simeprevir plasma concentrations has not been described in treated patients affected by chronic hepatitis C and with dermatological side-effects. In this study, we have evaluated a possible relationship between plasma levels and the onset of skin complaints for the first time.

Role of simeprevir plasma concentrations in HCV treated patients with dermatological symptoms

BOGLIONE, Lucio
First
;
DE NICOLO', AMEDEO;MORNESE PINNA, SIMONE;CUSATO, JESSICA;FAVATA, FABIO;ARIAUDO, ALESSANDRA;CARCIERI, CHIARA;DI PERRI, Giovanni;D'AVOLIO, ANTONIO
Last
2017-01-01

Abstract

Up till now the role of simeprevir plasma concentrations has not been described in treated patients affected by chronic hepatitis C and with dermatological side-effects. In this study, we have evaluated a possible relationship between plasma levels and the onset of skin complaints for the first time.
2017
49
6
705
708
Dermatological side-effects; HCV; Pharmacokinetics; Simeprevir; Therapeutic drug monitoring
Boglione, Lucio; De Nicolò, Amedeo; Mornese Pinna, Simone; Cusato, Jessica; Favata, Fabio; Ariaudo, Alessandra; Carcieri, Chiara; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1590865817301482-main (1).pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 387.26 kB
Formato Adobe PDF
387.26 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1627910
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact